AstraZeneca to Launch 100 New Medicines in China, Boosting Shanghai R&D Collaboration
AstraZeneca plans to launch over 100 new medicines in China within five years, strengthening collaboration through its Shanghai R&D center, according to EVP Sharon Barr.